Replimune Group, Inc.
REPL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737953
In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Replimune Group, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 144
- −4 vs. Q2 2024
- Shares held
- 69.9M
- +3.76M (+5.7%) vs. Q2 2024
- Total value
- $766.7M
- +$171.0M (+28.7%) vs. Q2 2024
- New holders
- 23
- 55 more added
- Sold out
- 27
- 41 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting REPL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 199 | $1.06B |
| Q1 2026 | 180 | $619.2M |
| Q4 2025 | 165 | $775.2M |
| Q3 2025 | 163 | $347.5M |
| Q2 2025 | 175 | $752.1M |
| Q1 2025 | 167 | $799.3M |
| Q4 2024 | 157 | $943.2M |
| Q3 2024 | 144 | $766.7M |
| Q2 2024 | 149 | $638.1M |
| Q1 2024 | 150 | $547.8M |
| Q4 2023 | 140 | $556.8M |
| Q3 2023 | 127 | $970.9M |
| Q2 2023 | 141 | $1.27B |
| Q1 2023 | 140 | $949.0M |
| Q4 2022 | 135 | $1.31B |
| Q3 2022 | 106 | $703.9M |
| Q2 2022 | 102 | $700.2M |
| Q1 2022 | 107 | $665.0M |
| Q4 2021 | 99 | $1.05B |
| Q3 2021 | 101 | $1.05B |
| Q2 2021 | 110 | $1.34B |
| Q1 2021 | 108 | $1.06B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Replimune Group, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| PDT Partners, LLC | 158,770 | $1.74M | 0.15% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 162,625 | $1.78M | 0.00% | −17,601−9.8% | Reduced |
| Two Sigma Investments, LP | 179,240 | $1.96M | 0.00% | −27,780−13.4% | Reduced |
| Invesco Ltd. | 180,958 | $1.98M | 0.00% | +95,360+111.4% | Added |
| Manufacturers Life Insurance Company, The | 184,208 | $2.02M | 0.00% | +36,689+24.9% | Added |
| Two Sigma Advisers, LP | 188,400 | $2.06M | 0.00% | −21,300−10.2% | Reduced |
| UBS Oconnor LLC | 193,122 | $2.12M | 0.05% | −13,314−6.4% | Reduced |
| Wellington Management Group LLP | 242,398 | $2.66M | 0.00% | −163,118−40.2% | Reduced |
| JPMorgan Chase & Co | 249,349 | $2.73M | 0.00% | +8,074+3.3% | Added |
| Jane Street Group, LLC | 262,248 | $2.87M | 0.00% | −274,078−51.1% | Reduced |
| TD Asset Management Inc | 257,622 | $2.88M | 0.00% | +7,682+3.1% | Added |
| Trexquant Investment LP | 266,471 | $2.92M | 0.04% | +205,273+335.4% | Added |
| Nan Fung Group Holdings Ltd | 287,846 | $3.15M | 2.72% | +82,907+40.5% | Added |
| Nuveen Asset Management, LLC | 319,641 | $3.50M | 0.00% | +87,674+37.8% | Added |
| Woodline Partners LP | 332,943 | $3.65M | 0.03% | +39,321+13.4% | Added |
| Norges Bank | 379,400 | $4.16M | 0.00% | −80,500−17.5% | Reduced |
| ExodusPoint Capital Management, LP | 422,914 | $4.63M | 0.05% | +422,914 | New |
| Ghost Tree Capital, LLC | 450,000 | $4.93M | 1.68% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 484,797 | $5.31M | 0.00% | +52,498+12.1% | Added |
| Alliancebernstein L.P. | 489,009 | $5.36M | 0.00% | +421,029+619.3% | Added |
| Deutsche Bank AG | 535,640 | $5.87M | 0.00% | +7,504+1.4% | Added |
| Dimensional Fund Advisors LP | 545,341 | $5.98M | 0.00% | −65,340−10.7% | Reduced |
| Northern Trust Corp | 549,501 | $6.02M | 0.00% | +86,242+18.6% | Added |
| Schonfeld Strategic Advisors LLC | 572,227 | $6.27M | 0.05% | −409,008−41.7% | Reduced |
| Goldman Sachs Group Inc | 619,512 | $6.79M | 0.00% | −46,565−7.0% | Reduced |
| FMR LLC | 626,412 | $6.87M | 0.00% | −120,776−16.2% | Reduced |
| Parkman Healthcare Partners LLC | 763,747 | $8.37M | 1.07% | +238,747+45.5% | Added |
| EcoR1 Capital, LLC | 850,341 | $9.32M | 0.32% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 867,683 | $9.51M | 0.01% | −64,097−6.9% | Reduced |
| RTW Investments, LP | 1,133,787 | $12.4M | 0.18% | 00.0% | Unchanged |
| Millennium Management LLC | 1,154,821 | $12.7M | 0.01% | −1,963,214−63.0% | Reduced |
| Tang Capital Management LLC | 1,200,000 | $13.2M | 0.94% | +394,560+49.0% | Added |
| Geode Capital Management, LLC | 1,428,301 | $15.7M | 0.00% | +217,308+17.9% | Added |
| Boxer Capital, LLC | 1,536,341 | $16.8M | 0.83% | 00.0% | Unchanged |
| Morgan Stanley | 1,689,803 | $18.5M | 0.00% | −45,851−2.6% | Reduced |
| State Street Corp | 2,340,042 | $25.6M | 0.00% | +1,182,181+102.1% | Added |
| Omega Fund Management, LLC | 2,461,319 | $27.0M | 16.86% | 00.0% | Unchanged |
| Braidwell LP | 3,070,837 | $33.7M | 0.95% | +2,057,460+203.0% | Added |
| Vanguard Group Inc | 3,466,247 | $38.0M | 0.00% | +571,133+19.7% | Added |
| Redmile Group, LLC | 4,781,183 | $52.4M | 3.09% | −780,913−14.0% | Reduced |
| FCPM III Services B.V. | 4,866,449 | $53.3M | 9.16% | 00.0% | Unchanged |
| BlackRock, Inc. | 5,471,564 | $60.0M | 0.00% | +5,471,564 | New |
| Price T Rowe Associates Inc | 9,879,250 | $108.3M | 0.01% | +643,193+7.0% | Added |
| Baker Bros. Advisors LP | 11,045,336 | $121.1M | 1.25% | +1,000,000+10.0% | Added |
| Atlas Venture Life Science Advisors, LLC | 0 | $0 | 0.00% | −2,098,300−100.0% | Sold out |
| Camber Capital Management LP | 0 | $0 | 0.00% | −1,350,000−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −185,516−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −184,761−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −145,919−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −72,207−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −70,113−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −66,071−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −57,043−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −52,112−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −49,754−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −49,261−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −42,820−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −39,170−100.0% | Sold out |
| Pennant Investors, LP | 0 | $0 | 0.00% | −30,500−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −29,460−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −29,300−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −29,344−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −19,707−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −18,555−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −14,505−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −12,029−100.0% | Sold out |
| Diversified Trust Co | 0 | $0 | 0.00% | −11,638−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −11,134−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −8,051−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −6,325−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |